Back

Watch Compare

Microbot Medical Inc.

Data quality: 83%

MBOT

NASDAQ Manufacturing Measuring & Analyzing Instruments

$2.39

▼ $0.04 (-1.65%)

6 months return

—

Momentum

Neutral

ROE

-24.21%

Growth

Revenue Growth (5Y)

N/A

Revenue (1Y)N/A

Earnings (1Y)N/A

FCF Growth (3Y)N/A

Quality

Return on Equity

-24.21%

Above sector avg (-54.68%)

ROIC-21.33%

Net MarginN/A

Op. MarginN/A

Safety

Debt / Equity

N/A

Current Ratio27.53

Interest CoverageN/A

Valuation

PE (TTM|NTM)

-12.44 | -7.85

Below sector avg (-1.49)

P/B Ratio2.09

EV/EBITDAN/A

Dividend YieldN/A

Quick Summary

Key Takeaways

Short bullets derived from reported financials—not the AI summary above.

Negative free cash flow of -13.11 M

Price History

Financial Trends

Analyst Price Target

3 analysts

Buy

+213.8%

upside to target

Current

$2.39

Consensus Target

$7.50

$5.00

Low

$12.00

High

Forecast

Forward P/E

-7.85

Forward EPS

-$0.33

Est. Revenue

9.46 M

Earnings Surprises

EPS

Reported Estimate Forecast

Next: Q1 2026 · EPS Est: -$0.07 · Rev Est: 0.0

	Q12025	Q22025	Q32025	Q42025	Q1 '26	Q2 '26
Reported	-$0.08	-$0.10	-$0.07	-$0.04	—	—
Estimate	-$0.13	-$0.08	-$0.06	-$0.06	-$0.07	-$0.08
Surprise	+38.46%	-25.00%	-16.67%	+33.33%	—	—

Growth

Rev 5Y: N/A · Earnings 1Y: N/A

Revenue Growth (1Y)	N/A	Revenue Growth (3Y)	N/A
Earnings Growth (1Y)	N/A	Earnings Growth (3Y)	N/A
Revenue Growth (5Y)	N/A	Earnings Growth (5Y)	N/A

Profitability

ROE: -24.21% · Net Margin: N/A

Revenue (TTM)	N/A	Net Income (TTM)	-13.14 M
ROE	-24.21%	ROA	-22.88%
Gross Margin	N/A	Operating Margin	N/A
Net Margin	N/A	Free Cash Flow (TTM)	-13.11 M
ROIC	-21.33%	FCF Growth (3Y)	N/A

Safety

D/E: N/A · Current: 27.53

Debt / Equity	N/A	Current Ratio	27.53
Interest Coverage	N/A	Asset Turnover	N/A
Working Capital	77.85 M	Tangible Book Value	78.22 M

Dividends

Yield: N/A · Payout: N/A

Dividend Yield	N/A	Payout Ratio	N/A
Dividend Growth (3Y)	N/A	Dividend Growth (5Y)	N/A
Consecutive Div Years	N/A

Valuation

P/E: -12.44 · EV/EBITDA: N/A

P/E Ratio	-12.44	Forward P/E	-7.85
P/B Ratio	2.09	P/S Ratio	N/A
PEG Ratio	N/A	Forward PEG	N/A
EV/EBITDA	N/A	Fwd EV/EBITDA	N/A
Forward P/S	17.28	Fwd Earnings Yield	N/A
FCF Yield	-8.01%
Market Cap	163.53 M	Enterprise Value	156.83 M

Per Share

EPS: -0.29 · FCF/Share: -0.20

EPS (Diluted TTM)	-0.29	Revenue / Share	N/A
FCF / Share	-0.20	OCF / Share	-0.19
EPS CAGR (1Y)	N/A	EPS CAGR (5Y)	N/A
EPS CAGR (10Y)	N/A

Efficiency

FCF Conv: 99.73% · CapEx/Rev: N/A

CapEx / Revenue	N/A	FCF Conversion	99.73%
SBC-Adj. FCF	-14.21 M	Growth Momentum	N/A

Income Statement

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	—	—	—	—	—
Net Income	-13.14 M	-11.44 M	-10.74 M	-13.17 M	-11.31 M
EPS (Diluted)	-0.29	-0.73	-1.05	—	—
Gross Profit	—	—	—	—	—
Operating Income	-14.74 M	-11.63 M	-9.86 M	-13.28 M	-11.36 M
EBITDA	—	—	—	—	—
R&D Expenses	6.28 M	6.63 M	5.72 M	7.74 M	6.15 M
SG&A Expenses	8.46 M	—	—	—	—
D&A	47,000.0	91,000.0	106,000.0	102,000.0	76,000.0
Interest Expense	—	—	—	—	—
Income Tax	—	—	—	—	—

Balance Sheet

Annual, most recent first

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Total Assets	81.54 M	6.03 M	8.33 M	9.54 M	16.77 M
Total Liabilities	3.99 M	2.50 M	3.83 M	2.25 M	2.39 M
Shareholders' Equity	77.55 M	3.53 M	4.50 M	7.29 M	14.38 M
Total Debt	—	—	—	—	—
Cash & Equivalents	3.91 M	3.11 M	2.47 M	2.44 M	13.49 M
Current Assets	79.82 M	5.82 M	7.92 M	8.81 M	15.88 M
Current Liabilities	3.42 M	2.46 M	3.79 M	2.07 M	1.98 M

Peer Comparison

vs Manufacturing sector median (1605 peers)

Metric	Stock	Sector Median
P/E	-12.4	-1.5
P/B	2.1	1.6
ROE %	-24.2	-54.7
Net Margin %	—	-41.5
Rev Growth 5Y %	—	1.8
D/E	—	0.3

ETFs Holding This Stock

BRUSX BRUSX

0.25% weight